Clinical trial / 2016
Adding flaxseed to lifestyle advice reduced metabolic syndrome prevalence and insulin resistance
A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.
- Study type
- Randomized controlled trial
- Who was studied
- 44 patients with metabolic syndrome
- What was measured
- Metabolic syndrome status, central obesity, insulin resistance, anthropometrics, blood pressure
THE PAPER
Flaxseed Supplementation in Metabolic Syndrome Management: A Pilot Randomized, Open-labeled, Controlled Study.
Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A. Phytother Res, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.